Sanofi Updates on Voting Rights and Shares: Key Figures Revealed

Sanofi’s Recent Disclosure on Voting Rights and Shares
In the world of corporate governance, transparency is essential, especially when it comes to shareholder rights. Sanofi has recently communicated important information about its voting rights and shares, adhering to regulations set forth by the French Commercial Code and the French stock market authority. This clarity is critical for investors and stakeholders alike.
Company Overview
Sanofi is a renowned French société anonyme, showcasing a registered share capital of €2,452,461,656. With its registered office located in Paris, this major pharmaceutical player is listed in the Paris Commercial and Companies Registry, under the number 395 030 844. Investors often seek clarity on such matters to make informed decisions regarding their investments.
Understanding Voting Rights
Key Figures as of May 31, 2025
Sanofi's latest report revealed several essential statistics regarding their shares:
The total number of issued shares stands at an impressive 1,227,755,892. In determining the voting rights associated with these shares, Sanofi has noted that there are 1,351,729,644 real voting rights, which exclude treasury shares. Furthermore, when considering the theoretical number of voting rights, including treasury shares, the figure rises to 1,361,952,180. This comprehensive information helps investors gauge the power each share holds in the company's decision-making process.
Regulatory Compliance
Sanofi ensures its compliance with the relevant financial regulations by providing regular updates as mandated by the regulations of the French stock market authority. The data released is crucial for maintaining investor confidence and adhering to transparency standards.
How to Access Additional Information
For those interested in delving deeper into Sanofi's financials and regulatory information, further insights are conveniently available via Sanofi's official website under the "Regulated Information in France" section. Visiting the website ensures that all stakeholders can keep updated on critical information related to their investments.
Contact Investor Relations
For any inquiries or further information, Sanofi's Investor Relations Department is readily accessible. They encourage communication via email, ensuring that investors can pose questions and obtain precise answers regarding their shares and voting rights.
Frequently Asked Questions
What are the total issued shares of Sanofi?
The total issued shares of Sanofi amount to 1,227,755,892 as of May 31, 2025.
How many real voting rights does Sanofi have?
Sanofi has 1,351,729,644 real voting rights excluding treasury shares.
What is the theoretical number of voting rights including treasury shares?
The theoretical number of voting rights, which includes treasury shares, is 1,361,952,180.
How can I find more information on Sanofi's shares?
More information can be accessed on Sanofi's official website under the section titled "Regulated Information in France".
Who should I contact for investor relations?
Investors can reach out to Sanofi's Investor Relations Department via email at investor.relations@sanofi.com for any queries.
About The Author
Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.